IN VITRO IMMUNOTOXICITY OF MBP, A MAJOR METABOLITE OF DI-N-BUTYL PHTHALATE(DBP) ON SD RAT SPLENIC B CELLS AND HUMAN B LYMPHOMA CELLS

  • Juno H. Eom (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Chung, Seung-Tae (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Park, Jae-Hyun (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Lee, Jong-Kwon (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Oh, Hae-Young (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Kim, Hyung-Soo (Immunotoxicology Division, National Institute of Toxicological Research, Korea Food and Drug Administration)
  • Published : 2002.11.01

Abstract

Di-n-butyl phthalate(DBP) is one of the most commonly used phthalic acid esters(PAEs) as a plasticizer, a solvent or a component in cosmetic formulations. MBP(monobutyl phthalate) is a major metabolite of DBP. Although DBP has been identified as a reproductive toxicant in several animal species and also known as a endocrine disruptor, the direct or indirect immunomodulatory effect of DBP has been little reported.(omitted)

Keywords